About Progenerics Pharma
Progenerics Pharma is a company based in Hyderabad (India) founded in 2015. It operates as a B2B. The company has 27 employees. Progenerics Pharma offers products and services including Formulation Development and Analytical Development. Progenerics Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hyderabad, India
- Employees 27
- SectorsHealthcare
- Email••••••••
- Website progenericspharma.com
- Legal Name Progenerics Pharma Private Limited
- Date of Incorporation 05 Dec, 2015
- Jurisdiction Patancheru, Telangana, India
- Annual Revenue₹2.96 Cr
FY 2025 · +70% YoY
- Net Loss-₹1.46 Cr
FY 2025 · -49% margin
- EBITDA-₹0.58 Cr
FY 2025 · -20% margin
- Employee Count27
Associated legal entities of Progenerics Pharma
Progenerics Pharma operates through Progenerics Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Progenerics Pharma Private Limited CIN U24233TG2015PTC102075 | Active | 05 Dec 2015 | Patancheru, Telangana | ₹3.0 Cr | 27 | 3 | View details |
Products & Services of Progenerics Pharma
Progenerics Pharma offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Development.
Service for developing pharmaceutical formulations to aid market entry.
Development of analytical methods for drug safety and efficiency.
Board of directors of Progenerics Pharma Private Limited (Progenerics Pharma)
Progenerics Pharma Private Limited is the primary company behind Progenerics Pharma. The board of Progenerics Pharma Private Limited currently have 3 directors; the longest-serving is Mamilla Nagarjun Reddy, appointed in 2024. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mamilla Nagarjun Reddy DIN 07579239 | Additional Director | 30 Dec 2024 | 1 yr 9 mo | Progenerics Pharma Private Limited |
| Sandeep Kondapalli Reddy DIN 09598119 | Additional Director | 30 Dec 2024 | 1 yr 9 mo | Progenerics Pharma Private Limited |
| Kotla Suraj Reddy DIN 08050711 | Additional Director | 30 Dec 2024 | 1 yr 9 mo | Progenerics Pharma Private Limited |
Financials of Progenerics Pharma
Figures of Progenerics Pharma Private Limited, the primary company behind Progenerics Pharma, for FY 2025. Revenue was ₹2.96 Cr (+70% year on year). Net loss was -₹1.46 Cr (-49% margin). EBITDA was -₹0.58 Cr (-20% margin). Revenue has grown at a compounded annual rate of -29% over three years and -12% over five years.
- ₹2.96 CrRevenue · FY 2025 · +70% YoY
- -₹1.46 CrNet loss · -49% margin
- -₹0.58 CrEBITDA · -20% margin
- ₹6.83 CrPaid-up capital
- 27Employees (provident fund records)
- -29%Revenue CAGR, 3 years
- -12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Progenerics Pharma Private Limited are on its company page.
Detailed financial statements for Progenerics Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Progenerics Pharma
Progenerics Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Progenerics Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Progenerics Pharma
10 companies that operate in the same segment as Progenerics Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Progenerics Pharma
Progenerics Pharma was founded in 2015.
Progenerics Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Progenerics Pharma has 27 employees.
The primary company behind Progenerics Pharma, Progenerics Pharma Private Limited, reported revenue of ₹2.96 Cr for FY 2025, up 70% year on year.
Progenerics Pharma Private Limited, located in Hyderabad, India, delivers flexible pharmaceutical solutions to help clients achieve early market entry. They specialize in formulation development and analytical development, emphasizing personalized, responsive services that prioritize safety and cost-efficiency. The company differentiates itself by addressing individual customer needs through partnerships, enabling efficient drug development processes without promotional claims.
Progenerics Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Progenerics Pharma offers Formulation Development and Analytical Development.
Progenerics Pharma operates through Progenerics Pharma Private Limited.
The legal entities of Progenerics Pharma currently have 3 directors, including Mamilla Nagarjun Reddy, Sandeep Kondapalli Reddy, Kotla Suraj Reddy.